戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 on, in consultation with the patient, should decide which anaesthetic technique to use on an individu
2                  The major challenge lies in deciding which are causal.
3 imal to a 1.5-T MR imaging unit and randomly decided which artery would be treated with MR-guided PTA
4 w medical charts, researchers must carefully decide which codes would best suit their studies.
5             These results may be of value in deciding which critically ill patients will benefit from
6 vides a single statistically valid guide for deciding which data are useful.
7 signing the protocol of a systematic review, deciding which data can be combined, and determining whe
8 r puzzle of decision making is how the brain decides which decision system to use at any one time.
9        Second, these results are useful when deciding which dye pairs to use for nucleic acids analys
10 shown pairs of human faces and instructed to decide which face was more attractive.
11 spondence problem is solved, that is, before deciding which features in the left and right images are
12 l to support the decision-making process, to decide which fragment to take to further optimization.
13                                     However, deciding which gene products are ideal drug/vaccine targ
14  gene is not feasible, a method is needed to decide which genes are worth investigating further.
15 s important information that may guide us in deciding which genes to test for and allows us to counse
16 od thus provides unbiased starting points in deciding which genomic regions and which genes in partic
17 required to perceive the visual stimulus and decide which hand to react with; the second included onl
18                                              Deciding which hand to use for an action is one of the m
19                 Many existing algorithms for deciding which hits should be sent for confirmatory test
20 eloping such models it is a daunting task to decide which, if any, coarse-grained model would be appr
21 ation risk, and it provided no assistance in deciding which individuals to prioritize for LTBI treatm
22 ies is that users currently have no means to decide which insertion and deletion (indel) parameters t
23 der to (in)validate network topologies or to decide which interactions are present or inactive in a g
24                                              Deciding which interventions have most impact on reducin
25 assist physicians and other policy-makers in deciding which interventions to provide for broad popula
26                            The difficulty in deciding which investigations to use and how to interpre
27 of "effectiveness" may be broadly helpful in deciding which markers or exposures are useful in diseas
28 e provided some guidelines for scientists to decide which method should be used in the discriminant a
29 nservation practitioners or policymakers, to decide which method to use as a basis for decision-makin
30                                              Deciding which new vaccines a country should invest in r
31  a sophisticated algorithm is constructed to decide which of the individual one-dimensional peaks hav
32  many patients with CMT make it difficult to decide which of the over 35 known CMT genes are affected
33 l cortex and read out this representation to decide which of two or more alternatives is more likely.
34                   Behaviorally, participants decided which of two letters occurred at a given positio
35                                 Participants decided which of two letters occurred at a given positio
36                                 Participants decided which of two simultaneously presented numbers wa
37 temporally dissociable phases while subjects decided which of two unfamiliar faces they preferred.
38 n female mammals a "random choice" mechanism decides which of the two X chromosomes will be inactivat
39                                              Deciding which of these approaches has greater merit is
40 ology detection, which makes it difficult to decide which one to choose for a particular application.
41 lved in mediating both responses, how a cell decides which pathway to take is not well established.
42               Age and comorbidities can help decide which patients may benefit from a CIT approach.
43 ore, further investigations are necessary to decide which patients require treatment and which do not
44 e laboratory tests and clinical suspicion to decide which patients with abdominal pain to refer to a
45  most difficult aspect of genetic testing is deciding which patients and families should undergo the
46 cs and early response assessment will aid in deciding which patients are most likely to benefit from
47                    These results may help in deciding which patients are most likely to benefit from
48  be considered when prescribing ICS and when deciding which patients might need more intensive follow
49 ria and risk assignment and may also vary in deciding which patients require intervention.
50                                              Deciding which patients should be offered surgery, and w
51                                              Deciding which patients should receive thrombolytic ther
52       These results may serve as a basis for deciding which patients with low LDL-C may be considered
53 iming of end-points, thus the brain needs to decide which properties of movements should be improved;
54                This study is informative for deciding which proteasome inhibitor to use for treating
55 ores that let automated annotation pipelines decide which proteins are members, and annotations for t
56 ed interactions but it is often difficult to decide which proteins to probe as interaction partners.
57 on's (WTO's) 144 member states are presently deciding which public services to open to foreign compet
58 ill serve as guides to researchers trying to decide which regions of the genome should be studied fur
59 res, despite this being a critical factor in deciding which reoperative procedure to choose.
60 s in making the right decision when they are deciding which route to take.
61        It is ultimately the application that decides which separator is most suitable.
62 he Analysis of Variance (ANOVA) framework to decide which sibling probe sets can be consolidated.
63 ic variation could have clinical utility for deciding which single-seizure individuals are likely to
64                                              Deciding which SNPs merit follow-up is one of the most c
65 om the environment and from other workers to decide which task to perform.
66 om social interactions with other workers in deciding which task to perform.
67 to this area, however, it can be daunting to decide which techniques or equipment to try.
68 oxygen demand after surgery rather than from deciding which tests optimally predict adverse events.
69 can assist clinicians and drug developers in deciding which theranostic targets should be taken for f
70 y minimizing cost, the unit commitment model decides which thermal power plants will be utilized base
71  surgical instruments to support surgeons to decide, which tissue areas should be removed and which s
72 tent and progression of NET are necessary to decide which treatment option to choose.
73                                           In deciding which treatment strategy would be suitable for
74            Physicians can best help patients decide which treatments are appropriate by taking the ne
75                                    How cells decide which way to die is unclear.
76                                           To decide which way to turn to reach a goal, forward infere

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。